A case report: interstitial pneumonia following treatment of gastric cancer with sintilimab in combination with S-1
BackgroundInterstitial pneumonia is a group of pathologies affecting the pulmonary interstitium, characterized by interstitial fibrosis and extensive alveolar consolidation. This disease can extend to the surrounding blood vessels and pulmonary interstitium, sometimes affecting the entire lung, resu...
Saved in:
Main Authors: | Pei Zhu, Qingming Sun, Sheng Xu, Wanhui Dong |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-02-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1508558/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Desquamative interstitial pneumonia: If there is smoke there is fire
by: Amit Panjwani, et al.
Published: (2023-12-01) -
Interstitial pneumonia due to Japanese spotted fever
by: Katsunori Arai, et al.
Published: (2025-01-01) -
Case report: Chemotherapy plus sintilimab for the treatment of gastroesophageal junction hepatoid adenocarcinoma with liver metastasis: a case study with literature review
by: Genlin Lu, et al.
Published: (2025-01-01) -
The efficacy and safety of induction chemotherapy combined with sintilimab followed by concurrent chemoradiotherapy plus sintilimab sequencing maintaining with sintilimab for patients with unresectable locally advanced esophageal squamous cell carcinoma
by: Ruifeng Wang, et al.
Published: (2025-01-01) -
Donafenib combined with sintilimab for advanced hepatocellular carcinoma: a single arm phase II trial
by: Xiaoyang Hong, et al.
Published: (2025-02-01)